GQ Asset Management »

Iovance Biotherapeutics shares owned by GQ Asset Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by GQ Asset Management from 13F filings

Historical chart of GQ Asset Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by GQ Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by GQ Asset Management

Quarter filed Position value Share count Share price at filing
2020-03-31 $81k 2.7k 30.06

More positions owned by GQ Asset Management

iShares Lehman Aggregate Bond (AGG)
Invesco Exchange W&p 500 Qualit equities (SPHQ)
Ishares Tr Msci Usa Momentum Factor (MTUM)
Costco Wholesale Corporation (COST)
Dollar General (DG)
Tesla Motors (TSLA)
Dex (DXCM)
Advanced Micro Devices (AMD)
Tyler Technologies (TYL)
Teladoc (TDOC)
Citrix Systems
Campbell Soup Company (CPB)
Kroger (KR)
Target Corporation (TGT)
Pfizer (PFE)

View all positions for GQ Asset Management

Top funds holding Iovance Biotherapeutics

Vanguard Group
Perceptive Advisors
MHR Fund Management
BlackRock
State Street Corporation
Soleus Capital Management
Hood River Capital Management
T. Rowe Price Investment Management
Geode Capital Management
Balyasny Asset Management
Artisan Partners Limited Partnership
Long Focus Capital Management
Goldman Sachs Group
venBio Select Advisor
Principal Financial Group

View all funds holding Iovance Biotherapeutics